⌘K

Kissei Pharmaceutical (4547) · InitiativeFirst stated

Clarification of the CFO’s responsibility for financial management

First written in FY2024-Q3. . Latest entry: FY2024-Q3.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Clarifying financial responsibility through the head of the Financial Management Department also serving as CFOA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first

FY2024-Q3First statedAnnual report
「Managing Executive Officer, Head of Financial Management Department and Chief Financial Officer (CFO)」
The Company disclosed a change in the position of the Head of the Financial Management Department, who would concurrently assume the duties of Chief Financial Officer (CFO), effective 1 October 2023, clarifying responsibility for financial management.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

Kissei Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.

Clarification of the CFO’s responsibility for financial management | KISSEI PHARMACEUTICAL CO.,LTD. (4547) | Komori